Pubblicazioni 2010

In ordine alfabetico per rivista scientifica - aggiornato a: 04 maggio 2011

1. Bleeker FE, Atai NA, Lamba S, Jonker A, Rijkeboer D, Bosch KS, Tigchelaar W, Troost D, Vandertop WP, Bardelli A, Van Noorden CJ.
   The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.
   Acta Neuropathol. 2010, Apr;119(4); 487-94. IF: 6.397
2. Zecchini S, Cavallaro U.
   Neural Cell Adhesion Molecule in Cancer: Expression and Mechanisms.
   Adv Exp Med Biol. 2010, 663; 319-333. IF: 2.020


3. Boniolo G, DI Fiore PP, Pece S.
   Trusted consent and research biobanks: towards a 'new alliance' between researchers and donors.
   Bioethics. 2010, May-17. IF: 4.000


4. Hermans K, Claes F, Vandevelde W, Zheng W, Geudens I, Orsenigo F, De Smet F, Gjini E, Anthonis K, Ren B, Kerjaschki D, Autiero M, Ny A, Simons M, Dewerchin M, Schulte-Merker S, Dejana E, Alitalo K, Carmeliet P.
   Role of synectin in lymphatic development in zebrafish and frogs.
   Blood. 2010, Jul 14. IF: 10.555


5. Licciulli S, Luise C, Zanardi A, Giorgetti L, Viale G, Lanfrancone L, Carbone R, Alcalay M.
   Pirin delocalization in melanoma progression identified by high content immuno-detection based approaches.
   BMC Cell Biol. 2010, Jan 20;11; 5. IF: 2.654


6. Theodoratou E, Campbell H, Tenesa A, Houlston R, Webb E, Lubbe S, Broderick P, Gallinger S, Croitoru EM, Jenkins MA, Win AK, Cleary SP, Koessler T, Pharoah PD, Küry S, Bézieau S, Buecher B, Ellis NA, Peterlongo P, Offit K, Aaltonen LA, Enholm S, Lindblom A, Zhou XL, Tomlinson IP, Moreno V, Blanco I, Capellà G, Barnetson R, Porteous ME, Dunlop MG, Farrington SM.
   A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.
   Br J Cancer. 2010, Dec 7;103(12); 1875-84. IF: 4.346


7. Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäkix I, Tuupanenx S, Aaltonen LA, Hemminki K, Lindblom A, Försti A, Sieber O, Lipton L, van Wezel T, Morreau H, Wijnen JT, Devilee P, Matsuda K, Nakamura Y, Castellví-Bel S, Ruiz-Ponte C, Castells A, Carracedo A, Ho JW, Sham P, Hofstra RM, Vodicka P, Brenner H, Hampe J, Schafmayer C, Tepel J, Schreiber S, Völzke H, Lerch MM, Schmidt CA, Buch S, Moreno V, Villanueva CM, Peterlongo P, Radice P, Echeverry MM, Velez A, Carvajal-Carmona L, Scott R, Penegar S, Broderick P, Tenesa A, Houlston RS.
   COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.
   Br J Cancer. 2010, Jan 19;102(2) :447-54. IF: 4.346


8. Zecchin D, Bardelli A.
   Tracking the genomic evolution of breast cancer metastasis.
   Breast Cancer Res. 2010, Feb 2;12(1); 302. IF: 5.326


9. Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S, Gariboldi M, Pierotti MA, Daidone MG.
   Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.
   Breast Cancer Res Treat. 2010, Jul 13. IF:4.696


10. Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Lubinski J, on behalf of CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer: !kConFab, UCI, MAYO, MBCSG, ModSqad, NCI, NICCC, OCGN, OUH, PBCS, SMC, SWE-BRCA, UPENN, IHCC, CNIO, DKFZ, HEBON, EMBRACE, FCCC, GEMO, Breast Cancer Family Registry, MUV, CBCS, MSKCC, GOG, OSU CCG, UTBCS, GC-HBOC, HCSC, HEBCS, INHERIT BRCAs. Other CIMBA contributing members were acknowledged as follow: !kConFab: Chenevix-Trench G, Spurdle AB, Healey S, Chen X, Beesley J and !kConFab Investigators; UCI: Neuhausen SL, Ding YC; MAYO: Couch FJ, Wang X, Karaus M; MBCSG: Peterlongo P, Manoukian S, Peissel B, Bonanni B, Viel A, Radice P; ModSqad: Szabo CI, Foretova L, Zikan M, Poppe B; NCI: Mai PL, Greene MH; NICCC: Lejbkowicz F, Rennert G; OCGN: Andrulis IL, Ozcelik H, Glendon G; OUH: Thomassen M, Gerdes AM, Kruse TA; PBCS: Caligo MA, Lombardi G; SMC: Laitman Y, Kaufman B, Milgrom R, Cohen S, Gershoni-Baruch R, Dragan E, Friedman E; SWE-BRCA: Loman N, Karlsson P, Ehrencrona H, von Wachenfeldt A; UPENN: D'Andrea K, Domchek SM, Nathanson KL, Rebbeck TR; IHCC: Serrano P, Cybulski C, Debniak T, Górski B, Byrski T, Huzarski T, Gronwald J; CNIO: Osorio A, Yannoukakos D, Cusido M, Benítez J; DKFZ: Dünnebier T; HEBON: Hogervorst FBL, van Leeuwen FE, Hooning MJ, van Asperen CJ, Devilee P, Ligtenberg M, van der Luijt RB, Aalfs CM, Waisfisz Q, Blok MJ; EMBRACE: Easton D, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans G, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, McGuffog L; FCCC: Godwin AK; GEMO: Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M, Vénat-Bouvet L, Imyanitov E; Breast Cancer Family Registry: John EM, Buys SS, Daly M, Hopper J, Terry MB, Miron A, Yassin Y, Goldgar D; MUV: Singer CF, Gschwantler-Kaulich D, Pfeiler G, Dressler C; CBCS: Hansen TVO, ILUH: Agnarsson BA; MSKCC: Kirchhoff T, Pal P, Offit K; GOG: Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV; OSU CCG: Ewart Toland A; UTBCS: Allavena A; GC-HBOC: Versmold B, Wappenschmidt B, Engel C, Meindl A, Engert S, Arnold N, Fiebig B, Weber BHF, Niederacher D, Deissler H, Sutter C, Kast K, Preisler-Adams S; HCSC: Caldes T, de la Hoya M; HEBCS: Nevanlinna H, Aittomäki K; INHERIT BRCAs: Simard J, Song H.
    The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: Results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.
    Breast Cancer Res Treat. 2010, Oct 30. IF: 5.684


11. Zuradelli M, Peissel B, Manoukian S, Zaffaroni D, Barile M, Pensotti V, Cavallari U, Masci G, Mariette F, Benski AC, Santoro A, Radice P.
    Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics.
    Breast Cancer Res Treat. 2010, Nov;124(1); 251-8. IF: 4.696


12. Peterlongo P, Catucci I, Pasquini G, Verderio P, Peissel B, Barile M, Varesco L, Riboni M, Fortuzzi S, Manoukian S, Radice P.
    PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer.
    Breast Cancer Res Treat. 2010. IF: 4.696


13. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'Olio V, Peterlongo P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH, Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Sunde L, Cruger D, Birk Jensen U, Caligo M, Friedman E, Kaufman B, Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernström H, Lindblom A, Rantala J, Stenmark-Askmalm M, Melin B; SWE-BRCA, Nathanson K, Domchek S, Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Durán M, Tejada MI, Godino J, Benítez J, Hamann U, Kriege M, Hoogerbrugge N, van der Luijt RB, van Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst F, Rookus M; HEBON, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ, Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, de Pauw A, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Faivre L; GEMO, Loustalot C, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M, Vénat-Bouvet L; GEMO, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer Family Registry, Singer CF, Dressler AC, Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jønson L, Agnarsson BA, Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov E, Tihomirova L, Blanco I, Lazaro C, Ramus SJ, Sucheston L, Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel C, Meindl A, Lochmann M, Arnold N, Heidemann S, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Kast K, Schönbuchner I, Caldes T, de la Hoya M, Aittomäki K, Nevanlinna H, Simard J, Spurdle AB, Holland H, Chen X; !kConFab, Platte R, Chenevix-Trench G, Easton DF; CIMBA.
    Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
    Cancer Res. 2010, Dec 1;70(23); 9742-54. IF: 7.543


14. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.
    Single-Nucleotide Polymorphisms Inside MicroRNA Target Sites Influence Tumor Susceptibility .
    Cancer Res. 2010, Apr 1;70(7); 2789-98. IF: 7.543


15. Wolkenhauer O, Auffray C, Baltrusch S, Blüthgen N, Byrne H, Cascante M, Ciliberto A, Dale T, Drasdo D, Fell D, Ferrell JE Jr, Gallahan D, Gatenby R, Günther U, Harms BD, Herzel H, Junghanss C, Kunz M, van Leeuwen I, Lenormand P, Levi F, Linnebacher M, Lowengrub J, Maini PK, Malik A, Rateitschak K, Sansom O, Schäfer R, Schürrle K, Sers C, Schnell S, Shibata D, Tyson J, Vera J, White M, Zhivotovsky B, Jaster R.
    Systems Biologists Seek Fuller Integration of Systems Biology Approaches in New Cancer Research Programs.
    Cancer Res. 2010, Jan 1;70(1) Epub Dec 22. IF: 7.543


16. Murakami M., Francavilla C., Sica A., Mantovani A., Matteoli G., Iliev I.D., Rescigno M., Cavallaro U., and Dejana E.
    Inactivation of Junctional Adhesion Molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration.
    Cancer Res. 2010, Mar 1 70(5):1759-65. IF: 7.543


17. Sartore-Bianchi A, Bencardino K, Cassingena A, Venturini F, Funaioli C, Cipani T, Amatu A, Pietrogiovanna L, Schiavo R, Di Nicolantonio F, Artale S, Bardelli A, Siena S.
    Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancer.
    Cancer Treat Rev. 2010, Nov;36 Suppl 3:S1; 1-5. IF: 5.295


18. Salvatore Pece, Daniela Tosoni, Stefano Confalonieri, Giovanni Mazzarol, Manuela Vecchi, Simona Ronzoni, Loris Bernard, Giuseppe Viale, Pier Giuseppe Pelicci, Pier Paolo Di Fiore
    Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content.
    Cell. 2010, 140 (1); 62-73. IF: 31.152


19. Di Nicolantonio F, Arena S, Gallicchio and Bardelli A
    Isogenic mutant human cells as a new tool for personalized cancer medicine.
    Cell Cycle. 2010, Jan 1;9(1): 20-1. IF: 4.087


20. Liberi G, Foiani M.
    The double life of Holliday junctions.
    Cell Res. 2010, Jun;20(6); 611-3. IF: 8.151


21. Dejana E.
    The role of wnt signaling in physiological and pathological angiogenesis.
    Circ. Res. 2010, Oct 15;107(8); 943-52. IF: 9.214


22. Corada M, Nyqvist D, Orsenigo F, Caprini A, Giampietro C, Taketo MM, Iruela-Arispe ML, Adams RH, Dejana E.
    The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling.
    Developmental Cell. 2010, Jun 15;18(6); 938-49. IF: 13.363


23. Fernandez-Diaz LC, Laurent A, Girasoli S, Turco M, Longobardi E, Iotti G, Jenkins NA, Fiorenza MT, Copeland NG, Blasi F.
    The absence of Prep1 causes p53-dependent apoptosis of mouse pluripotent epiblast cells.
    Development. 2010, Oct;137(20); 3393-403. IF: 7.194


24. Vaccari T, Duchi S, Cortese K, Tacchetti C, Bilder D.
    The vacuolar ATPase is required for physiological as well as pathological activation of the Notch receptor.
    Development. 2010, 137:1825-32. IF: 7.194


25. Mione MC, Trede NS. Dis Model Mech
    The zebrafish as a model for cancer.
    Dis Model Mech. 2010, 3(9-10); 517-23. IF: 3.304


26. Carotenuto W, Liberi G.
    Mitotic inter-homologue junctions accumulate at damaged DNA replication forks in recQ mutants.
    DNA Repair (Amst). 2010, Jun 4;9(6):661-9. IF: 4.199


27. Palamidessi A, Testa I, Frittoli E, Barozzi S, Garrè M, Mazza D, Di Fiore PP, Diaspro A, Scita G, Faretta M.
    Understanding biological dynamics: following cells and molecules to track functions and mechanisms.
    Eur Biophys J. 2010, May;39(6); 947-57. IF: 2.437


28. Chiappetta G, Ottaiano A, Vuttariello E, Monaco M, Galdiero F, Gallipoli A, Pilotti S, Jodice G, Siranoush M, Colombo M, Ripamonti CB, Pallante PL, Radice P, Fusco A.
    HMGA1 protein expression in familial breast carcinoma patients.
    Eur J Cancer. 2010, Jan;46(2):332-9. IF: 4.475


29. Iodice S, Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P, Bernard L, Maisonneuve P, Gandini S.
    Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis
    Eur J Cancer. 2010, Aug;46(12); 2275-84. IF: 4.121


30. Ferrari E, Lucca C, Foiani M.
    A lethal combination for cancer cells: synthetic lethality screenings for drug discovery.
    Eur J Cancer. 2010, Nov;46(16); 2889-95. IF: 4.121


31. Welsch T, Younsi A, Disanza A, Rodriguez JA, Cuervo AM, Scita G, Schmidt J.
    Eps8 is recruited to lysosomes and subjected to chaperone-mediated autophagy in cancer cells.
    Exp Cell Res. 2010, Feb 22. IF: 3.589


32. Conradie R, Bruggeman FJ, Ciliberto A, Csikász-Nagy A, Novák B, Westerhoff HV, Snoep JL.
    Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex.
    FEBS J. 2010, Jan;277(2);357-67. IF: 3.042


33. Blasi F, Sidenius N.
    The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.
    FEBS Lett. 2010, May 3;584(9); 1923-30. IF: 3.541


34. Negri T, Tarantino E, Orsenigo M, Reid JF, Gariboldi M, Zambetti M, Pierotti MA, Pilotti S.
    Chromosome band 17q21 in breast cancer: significant association between beclin 1 loss and HER2/NEU amplification.
    Genes Chromosomes Cancer. 2010, Oct;49(10); 901-9. IF: 3.858


35. Branzei D, Foiani M.
    Leaping forks at inverted repeats.
    Genes Dev. 2010, Jan 1;24(1); 5-9. IF: 12.075


36. Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P, Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P, Burwinkel B, Peterlongo P.
    Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.
    Hum Mutat. 2010, Jan;31(1); E1052-7. IF: 7.033


37. Bombardelli L, Cavallaro U.
    Immunoglobulin-like cell adhesion molecules: Novel signaling players in epithelial ovarian cancer.
    Int J Biochem Cell Biol. 2010, Jan 18. IF: 4.887


38. Fernández-Ramires R, Gómez G, Muñoz-Repeto I, de Cecco L, Llort G, Cazorla A, Blanco I, Gariboldi M, Pierotti MA, Benítez J, Osorio A.
    Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.
    Int J Cancer. 2010, Aug 16. IF: 4.722


39. Hofman EG, Bader AN, Voortman J, van den Heuvel DJ, Sigismund S, Verkleij AJ, Gerritsen HC, van Bergen en Henegouwen PM.
    Ligand-induced EGF receptor oligomerization is kinase-dependent and enhances internalization.
    J Biol Chem. 2010, Dec 10;285(50); 39481-9. IF: 5.328


40. Lampugnani MG.
    Endothelial adherens junctions and the actin cytoskeleton: an 'infinity net'?
    J Biol. 2010, Apr 8;9(3); 16. NO IF.


41. Frosi Y, Anastasi S, Ballarò C, Varsano G, Castellani L, Maspero E, Polo S, Alemà S, Segatto O.
    A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation.
    J Cell Biol. 2010, May 3;189(3); 557-71. IF: 9.575


42. Manzoni R, Montani F, Visintin C, Caudron F, Ciliberto A, Visintin R.
    Oscillations in Cdc14 release and sequestration reveal a circuit underlying mitotic exit.
    J Cell Biol. 2010, Jul 26;190(2); 209-22. IF: 9.575


43. Di Fiore PP.
    Pier Paolo Di Fiore: plumbing the depths of endocytosis by Powell Kendall.
    J Cell Biol. 2010, Jan 11;188(1);4-5. IF: 9.575


44. Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, Dejana E.
    CCM1 regulates vascular-lumen organization by inducing endothelial polarity.
    J Cell Sci. 2010, Apr 1;123(Pt 7):1073-80. IF: 6.144


45. Bardelli A, Siena S.
    Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.
    J Clin Oncol. 2010, Mar 1;28(7); 1254-61. IF: 17.793


46. Bardelli A, Siena S.
    Reply to E. Hawkes and D. Cunningham.
    J Clin Oncol. 2010, Aug 2. IF: 17.793


47. Barbi S, Cataldo I, De Manzoni G, Bersani S, Lamba S, Mattuzzi S, Bardelli A, Scarpa A.
    The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.
    J Exp Clin Cancer Res. 2010, Apr 16 (29) 32. IF: 1.274


48. G Boniolo and P P Di Fiore
    Deliberative ethics in a biomedical institution:an example of integration between science and ethics.
    J Med Ethics. 2010, 36: 409-414. IF: 1.206


49. Verderio P, Pizzamiglio S, Southey MC, Spurdle AB, Hopper JL, Chen X, Beesley J; Australian Ovarian Cancer Study Group KConFab, Schmutzler RK, Engel C, Burwinkel B, Bugert P, Ficarazzi F, Manoukian S, Barile M, Wappenschmidt B, Chenevix-Trench G, Radice P, Peterlongo P.
    A BRCA1 promoter variant (rs11655505) and breast cancer risk.
    J Med Genet. 2010, Apr;47(4); 268-70. IF: 5.751


50. De Roock W, Jonker DJ, Di Nicolantonio F, Sartore-Bianchi A, Tu D, Siena S, Lamba S, Arena S, Frattini M, Piessevaux H, Van Cutsem E, O'Callaghan CJ, Khambata-Ford S, Zalcberg JR, Simes J, Karapetis CS, Bardelli A, Tejpar S.
    Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.
    JAMA. 2010, Oct 27;304(16); 1812-20. IF: 28.899


51. Di Nicolantonio F, Arena S, Tabernero J, Grosso S, Molinari F, Macarulla T, Russo M, Cancelliere C, Zecchin D, Mazzucchelli L, Sasazuki T, Shirasawa S, Geuna M, Frattini M, Baselga J, Gallicchio M, Biffo S and Bardelli A
    Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.
    Journal of Clinical Investigation. 2010, Aug 2;120(8): 2858-66. IF: 15.387


52. De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, Kalogeras KT, Kotoula V, Papamichael D, Laurent-Puig P, Penault-Llorca F, Rougier P, Vincenzi B, Santini D, Tonini G, Cappuzzo F, Frattini M, Molinari F, Saletti P, De Dosso S, Martini M, Bardelli A, Siena S, Sartore-Bianchi A, Tabernero J, Macarulla T, Di Fiore F, Gangloff AO, Ciardiello F, Pfeiffer P, Qvortrup C, Hansen TP, Van Cutsem E, Piessevaux H, Lambrechts D, Delorenzi M, Tejpar S.
    Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
    Lancet Oncol . 2010, Aug;11(8): 753-62. IF: 14.470


53. Casola S.
    Mouse models for miRNA expression: the ROSA26 locus.
    Methods Mol Biol. 2010, 667:145-63


54. Vicidomini G, Gagliani MC, Cortese K, Krieger J, Buescher P, Bianchini P, Boccacci P, Tacchetti C, and Diaspro A.
    A novel approach for correlative light electron microscopy analysis.
    Microsc Res Tech. 2010, 73:215-24. IF: 1.850


55. Choi K, Szakal B, Chen YH, Branzei D, Zhao X.
    The Smc5/6 Complex and Esc2 Influence Multiple Replication-associated Recombination Processes in Saccharomyces cerevisiae.
    Mol Biol Cell. 2010, May 5. IF: 5.979


56. Appendino G, Bardelli A.
    Broccoli, PTEN deletion and prostate cancer: where is the link?
    Mol Cancer. 2010, 9:189. IF: 4.160


57. Ward JD, Muzzini DM, Petalcorin MI, Martinez-Perez E, Martin JS, Plevani P, Cassata G, Marini F, Boulton SJ.
    Overlapping mechanisms promote postsynaptic RAD-51 filament disassembly during meiotic double-strand break repair.
    Mol Cell. 2010, Jan 29;37(2); 259-72. IF: 14.608


58. Fachinetti D, Bermejo R, Cocito A, Minardi S, Katou Y, Kanoh Y, Shirahige K, Azvolinsky A, Zakian VA, Foiani M.
    Replication termination at eukaryotic chromosomes is mediated by Top2 and occurs at genomic loci containing pausing elements.
    Mol Cell. 2010, Aug 27;39(4); 595-605. IF: 14.608


59. Grazini U, Zanardi F, Citterio E, Casola S, Goding CR, McBlane F.
    The RING domain of RAG1 ubiquitylates histone H3: a novel activity in chromatin-mediated regulation of V(D)J joining.
    Mol Cell. 2010, Jan 29;37(2); 282-93. IF: 14.608


60. Longobardi E, Iotti G, Di Rosa P, Mejetta S, Bianchi F, Fernandez-Diaz LC, Micali N, Nuciforo P, Lenti E, Ponzoni M, Doglioni C, Caniatti M, Di Fiore PP, Blasi F.
    Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EmuMyc lymphomagenesis: A tumor suppressor role for Prep1.
    Mol Oncol. 2010, Jan 7. IF: 2.661


61. Mariani L, Schulz EG, Lexberg MH, Helmstetter C, Radbruch A, Löhning M, Höfer T.
    Short-term memory in gene induction reveals the regulatory principle behind stochastic IL-4 expression.
    Mol Syst Biol. 2010, Apr 13;6; 359. IF: 12.125


62. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D; EMBRACE, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L, Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S, Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P; GEMO Study Collaborators, Hogervorst FB, Rookus MA, Jager A, van den Ouweland A, Hoogerbrugge N, van der Luijt RB, Meijers-Heijboer H, Gómez García EB; HEBON, Devilee P, Vreeswijk MP, Lubinski J, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Górski B, Cybulski C, Spurdle AB, Holland H; !kConFab, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Preisler-Adams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL, Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R, Andrulis IL, Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci C; SWE-BRCA, Loman N, Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen M, Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A, Radice P, Caldes T, de la Hoya M, Singer CF, Fink-Retter A, Greene MH, Mai PL, Loud JT, Guidugli L, Lindor NM, Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus SJ, Gayther SA, Phelan C, Narod S, Szabo CI; MOD SQUAD, Benítez J, Osorio A, Nevanlinna H, Heikkinen T, Caligo MA, Beattie MS, Hamann U, Godwin AK, Montagna M, Casella C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J, Olopade O, Simard J, Soucy P, Rubinstein WS, Arason A, Rennert G, Martin NG, Montgomery GW, Chang-Claude J, Flesch-Janys D, Brauch H; GENICA, Severi G, Baglietto L, Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D, Fountzilas G, Fasching PA, Beckmann MW, Dos Santos Silva I, Peto J, Lambrechts D, Paridaens R, Rüdiger T, Försti A, Winqvist R, Pylkäs K, Diasio RB, Lee AM, Eckel-Passow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah PP, Offit K, Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ.
    A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
    Nat Genet. 2010, Oct;42(10); 885-92. IF: 34.284


63. Branzei D, Foiani M.
    Maintaining genome stability at the replication fork.
    Nat Rev Mol Cell Biol. 2010, Mar;11(3); 208-19. IF: 42.198


64. International Cancer Genome Consortium, Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L, Nettekoven G, Ozenberger B, Peterson J, Rao TS, Remacle J, Schafer AJ, Shibata T, Stratton MR, Vockley JG, Watanabe K, Yang H, Yuen MM, Knoppers BM, Bobrow M, Cambon-Thomsen A, Dressler LG, Dyke SO, Joly Y, Kato K, Kennedy KL, Nicolás P, Parker MJ, Rial-Sebbag E, Romeo-Casabona CM, Shaw KM, Wallace S, Wiesner GL, Zeps N, Lichter P, Biankin AV, Chabannon C, Chin L, Clément B, de Alava E, Degos F, Ferguson ML, Geary P, Hayes DN, Hudson TJ, Johns AL, Kasprzyk A, Nakagawa H, Penny R, Piris MA, Sarin R, Scarpa A, Shibata T, van de Vijver M, Futreal PA, Aburatani H, Bayés M, Botwell DD, Campbell PJ, Estivill X, Gerhard DS, Grimmond SM, Gut I, Hirst M, López-Otín C, Majumder P, Marra M, McPherson JD, Nakagawa H, Ning Z, Puente XS, Ruan Y, Shibata T, Stratton MR, Stunnenberg HG, Swerdlow H, Velculescu VE, Wilson RK, Xue HH, Yang L, Spellman PT, Bader GD, Boutros PC, Campbell PJ, Flicek P, Getz G, Guigó R, Guo G, Haussler D, Heath S, Hubbard TJ, Jiang T, Jones SM, Li Q, López-Bigas N, Luo R, Muthuswamy L, Ouellette BF, Pearson JV, Puente XS, Quesada V, Raphael BJ, Sander C, Shibata T, Speed TP, Stein LD, Stuart JM, Teague JW, Totoki Y, Tsunoda T, Valencia A, Wheeler DA, Wu H, Zhao S, Zhou G, Stein LD, Guigó R, Hubbard TJ, Joly Y, Jones SM, Kasprzyk A, Lathrop M, López-Bigas N, Ouellette BF, Spellman PT, Teague JW, Thomas G, Valencia A, Yoshida T, Kennedy KL, Axton M, Dyke SO, Futreal PA, Gerhard DS, Gunter C, Guyer M, Hudson TJ, McPherson JD, Miller LJ, Ozenberger B, Shaw KM, Kasprzyk A, Stein LD, Zhang J, Haider SA, Wang J, Yung CK, Cross A, Liang Y, Gnaneshan S, Guberman J, Hsu J, Bobrow M, Chalmers DR, Hasel KW, Joly Y, Kaan TS, Kennedy KL, Knoppers BM, Lowrance WW, Masui T, Nicolás P, Rial-Sebbag E, Rodriguez LL, Vergely C, Yoshida T, Grimmond SM, Biankin AV, Bowtell DD, Cloonan N, deFazio A, Eshleman JR, Etemadmoghadam D, Gardiner BA, Kench JG, Scarpa A, Sutherland RL, Tempero MA, Waddell NJ, Wilson PJ, McPherson JD, Gallinger S, Tsao MS, Shaw PA, Petersen GM, Mukhopadhyay D, Chin L, DePinho RA, Thayer S, Muthuswamy L, Shazand K, Beck T, Sam M, Timms L, Ballin V, Lu Y, Ji J, Zhang X, Chen F, Hu X, Zhou G, Yang Q, Tian G, Zhang L, Xing X, Li X, Zhu Z, Yu Y, Yu J, Yang H, Lathrop M, Tost J, Brennan P, Holcatova I, Zaridze D, Brazma A, Egevard L, Prokhortchouk E, Banks RE, Uhlén M, Cambon-Thomsen A, Viksna J, Ponten F, Skryabin K, Stratton MR, Futreal PA, Birney E, Borg A, Børresen-Dale AL, Caldas C, Foekens JA, Martin S, Reis-Filho JS, Richardson AL, Sotiriou C, Stunnenberg HG, Thoms G, van de Vijver M, van't Veer L, Calvo F, Birnbaum D, Blanche H, Boucher P, Boyault S, Chabannon C, Gut I, Masson-Jacquemier JD, Lathrop M, Pauporté I, Pivot X, Vincent-Salomon A, Tabone E, Theillet C, Thomas G, Tost J, Treilleux I, Calvo F, Bioulac-Sage P, Clément B, Decaens T, Degos F, Franco D, Gut I, Gut M, Heath S, Lathrop M, Samuel D, Thomas G, Zucman-Rossi J, Lichter P, Eils R, Brors B, Korbel JO, Korshunov A, Landgraf P, Lehrach H, Pfister S, Radlwimmer B, Reifenberger G, Taylor MD, von Kalle C, Majumder PP, Sarin R, Rao TS, Bhan MK, Scarpa A, Pederzoli P, Lawlor RA, Delledonne M, Bardelli A, Biankin AV, Grimmond SM, Gress T, Klimstra D, Zamboni G, Shibata T, Nakamura Y, Nakagawa H, Kusada J, Tsunoda T, Miyano S, Aburatani H, Kato K, Fujimoto A, Yoshida T, Campo E, López-Otín C, Estivill X, Guigó R, de Sanjosé S, Piris MA, Montserrat E, González-Díaz M, Puente XS, Jares P, Valencia A, Himmelbaue H, Quesada V, Bea S, Stratton MR, Futreal PA, Campbell PJ, Vincent-Salomon A, Richardson AL, Reis-Filho JS, van de Vijver M, Thomas G, Masson-Jacquemier JD, Aparicio S, Borg A, Børresen-Dale AL, Caldas C, Foekens JA, Stunnenberg HG, van't Veer L, Easton DF, Spellman PT, Martin S, Barker AD, Chin L, Collins FS, Compton CC, Ferguson ML, Gerhard DS, Getz G, Gunter C, Guttmacher A, Guyer M, Hayes DN, Lander ES, Ozenberger B, Penny R, Peterson J, Sander C, Shaw KM, Speed TP, Spellman PT, Vockley JG, Wheeler DA, Wilson RK, Hudson TJ, Chin L, Knoppers BM, Lander ES, Lichter P, Stein LD, Stratton MR, Anderson W, Barker AD, Bell C, Bobrow M, Burke W, Collins FS, Compton CC, DePinho RA, Easton DF, Futreal PA, Gerhard DS, Green AR, Guyer M, Hamilton SR, Hubbard TJ, Kallioniemi OP, Kennedy KL, Ley TJ, Liu ET, Lu Y, Majumder P, Marra M, Ozenberger B, Peterson J, Schafer AJ, Spellman PT, Stunnenberg HG, Wainwright BJ, Wilson RK, Yang H.
    International network of cancer genome projects.
    Nature. 2010, 993-998. IF: 34.480


65. Scita G, Di Fiore PP.
    The endocytic matrix.
    Nature. 2010, Jan 28;463(7280); 464-73. IF: 34.480


66. Bruni T.
    Is Free Will a Necessary Condition for Instrumental Rationality?
    Neuroscience. 2010, 1: 4, 49 - 50 . IF: 3.292


67. Micali N, Longobardi E, Iotti G, Ferrai C, Castagnaro L, Ricciardi M, Blasi F, Crippa MP.
    Down syndrome fibroblasts and mouse Prep1-overexpressing cells display increased sensitivity to genotoxic stress.
    Nucleic Acids Res. 2010, Jan 27. IF: 7.479


68. Feng Y, Santoriello C, Mione M, Hurlstone A, Martin P
    Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation.
    PLoS Biol. 2010; 8(12): e1000562. IF: 12.916


69. Hertzog M, Milanesi F, Hazelwood L, Disanza A, Liu H, Perlade E, Malabarba MG, Pasqualato S, Maiolica A, Confalonieri S, Le Clainche C, Offenhauser N, Block J, Rottner K, Di Fiore PP, Carlier MF, Volkmann N, Hanein D, Scita G.
    Molecular basis for the dual function of Eps8 on actin dynamics: bundling and capping.
    PLoS Biol. 2010, Jun 1;8(6): e1000387.PMID: 20532239. IF: 12.916


70. De Grassi A, Segala C, Iannelli F, Volorio S, Bertario L, Radice P, Bernard L, Ciccarelli FD.
    Ultradeep Sequencing of a Human Ultraconserved Region Reveals Somatic and Constitutional Genomic Instability.
    PLoS Biol. 2010, Jan;8(1); e1000275. IF: 12.916


71. Saponaro M, Callahan D, Zheng X, Krejci L, Haber JE, Klein HL, Liberi G.
    Cdk1 targets Srs2 to complete synthesis-dependent strand annealing and to promote recombinational repair.
    PLoS Genet. 2010, Feb 26;6(2); e1000858. IF: 9.532


72. Solinger JA, Paolinelli R, Klöß H, Scorza FB, Marchesi S, Sauder U, Mitsushima D, Capuani F, Stürzenbaum SR, Cassata G.
    The Caenorhabditis elegans Elongator Complex Regulates Neuronal alpha-tubulin Acetylation.
    PLoS Genet. 2010, Jan 22;6(1); e1000820. IF: 9.532


73. Vanoli F, Fumasoni M, Szakal B, Maloisel L, Branzei D.
    Replication and recombination factors contributing to recombination-dependent bypass of DNA lesions by template switch. PLoS Genet. 2010, 11;6(11):e1001205. IF: 9.532


74. Santoriello C, Anelli V, Distel M, Kelly A, Koester RW, Hurlstone A, Mione M
    Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.
    PLoS One. 2010, 10;5(12):e15170. IF: 4.351


75. Tocchetti A, Ekalle Soppo CB, Zani F, Bianchi F, Gagliani MC, Pozzi B, Rozman J, Elvert R, Ehrhardt N, Rathkolb B, Moerth C, Horsch M, Fuchs H, Gailus-Durner V, Beckers J, Klingenspor M, Wolf E, de Angelis MH, Scanziani E, Tacchetti C, Scita G, Di Fiore PP, Offenhäuser N.
    Loss of the actin remodeler eps8 causes intestinal defects and improved metabolic status in mice.
    PLoS One. 2010, Mar 2;5(3) e9468. IF: 4.351


76. Corbo V, Ritelli R, Barbi S, Funel N, Campani D, Bardelli A, Scarpa A.
    Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.
    PLoS One. 2010, Sep 8;5(9); e12653. IF: 4.351


77. Bresciani E, Confalonieri S, Cermenati S, Cimbro S, Foglia E, Beltrame M, Di Fiore PP, Cotelli F.
    Zebrafish numb and numblike are involved in primitive erythrocyte differentiation.
    PLoS One. 2010, Dec 13;5(12); e14296. IF: 4.351


78. Boniolo G, D'Agostino M, Di Fiore PP.
    Zsyntax: a formal language for molecular biology with projected applications in text mining and biological prediction.
    PLoS One. 2010, Mar 3;5(3); e9511. IF: 4.351


79. Bernardi E, Deflorian G, Pezzimenti F, Diaz VM, Mione M, Blasi F.
    Characterization of the regulatory region of the zebrafish Prep1.1 gene: analogies to the promoter of the human PREP1.
    PLoS One. 2010, Dec 22;5(12):e15047. IF: 4.351


80. Loi S, Haibe-Kains B, Majjaj S, Lallemand F, Durbecq V, Larsimont D, Gonzalez-Angulo AM, Pusztai L, Symmans WF, Bardelli A, Ellis P, Tutt AN, Gillett CE, Hennessy BT, Mills GB, Phillips WA, Piccart MJ, Speed TP, McArthur GA, Sotiriou C.
    PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.
    Proc Natl Acad Sci U S A. 2010, Jun 1;107(22); 10208-13. IF: 9.432


81. Ko G, Paradise S, Chen H, Graham M, Vecchi M, Bianchi F, Cremona O, Di Fiore PP, De Camilli P.
    Selective high-level expression of epsin 3 in gastric parietal cells, where it is localized at endocytic sites of apical canaliculi.
    Proc Natl Acad Sci U S A. 2010, 29 NOV. IF: 9.432


82. Fanelli M, Amatori S, Barozzi I, Soncini M, Dal Zuffo R, Bucci G, Capra M, Quarto M, Dellino GI, Mercurio C, Alcalay M, Viale G, Pelicci PG, Minucci S.
    Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples.
    Proc Natl Acad Sci U S A. 2010, Nov. IF: 9.432


83. Dejana E, Nyqvist D.
    News from the brain: the GPR124 orphan receptor directs brain-specific angiogenesis.
    Science Transnational Medicine. 2010, Nov 17;2(58); 58ps53.


84. Giorgi C, Ito K, Lin HK, Santangelo C, Wieckowski MR, Lebiedzinska M, Bononi A, Bonora M, Duszynski J, Bernardi R, Rizzuto R, Tacchetti C, Pinton P, Pandolfi PP.
    PML regulates apoptosis at endoplasmic reticulum by modulating calcium release.
    Science. 2010, Nov 26;330(6008); 1247-51. IF: 29.747


85. Sartore-Bianchi A, Bencardino K, Di Nicolantonio F, Pozzi F, Funaioli C, Gambi V, Arena S, Martini M, Lamba S, Cassingena A, Schiavo R, Bardelli A, Siena S.
    Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.
    Target Oncol. 2010, Apr-11. IF: 0.455